Hormone Sensitive Breast Cancer Global Clinical Trials Review, H1, 2014


#191969

170pages

GlobalData

$ 2500

In Stock

 

GlobalData's clinical trial report, Hormone Sensitive Breast Cancer Global Clinical Trials Review, H1, 2014" provides data on the Hormone Sensitive Breast Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hormone Sensitive Breast Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hormone Sensitive Breast Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

 

Scope

 

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations 
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

 

Reasons to buy

 

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents


Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Hormone Sensitive Breast Cancer 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Hormone Sensitive Breast Cancer to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Hormone Sensitive Breast Cancer to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Hormone Sensitive Breast Cancer 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Hormone Sensitive Breast Cancer Therapeutics Clinical Trials 30
Prominent Drugs 32
Latest Clinical Trials News on Hormone Sensitive Breast Cancer 33
Dec 07, 2011: Study Finds Anti-Estrogen Combo Better Than Single Drug For Hormone Sensitive Breast Cancer 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
AstraZeneca PLC 34
Clinical Trial Overview of AstraZeneca PLC 34
Novartis AG 35
Clinical Trial Overview of Novartis AG 35
F. Hoffmann-La Roche Ltd. 36
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 36
Pfizer Inc. 37
Clinical Trial Overview of Pfizer Inc. 37
GlaxoSmithKline plc 38
Clinical Trial Overview of GlaxoSmithKline plc 38
Mylan Inc. 39
Clinical Trial Overview of Mylan Inc. 39
Medivation, Inc. 40
Clinical Trial Overview of Medivation, Inc. 40
Cipla Ltd. 41
Clinical Trial Overview of Cipla Ltd. 41
Bluefish Pharmaceuticals AB 42
Clinical Trial Overview of Bluefish Pharmaceuticals AB 42
Clinical Trial Overview of Top Institutes / Government 43
Vanderbilt-Ingram Cancer Center 43
Clinical Trial Overview of Vanderbilt-Ingram Cancer Center 43
Japan Breast Cancer Research Group 44
Clinical Trial Overview of Japan Breast Cancer Research Group 44
Asan Medical Center 45
Clinical Trial Overview of Asan Medical Center 45
British Columbia Cancer Agency 46
Clinical Trial Overview of British Columbia Cancer Agency 46
Saitama Medical University 47
Clinical Trial Overview of Saitama Medical University 47
Institut Claudius Regaud 48
Clinical Trial Overview of Institut Claudius Regaud 48
Institut Bergonie 49
Clinical Trial Overview of Institut Bergonie 49
Institut Curie 50
Clinical Trial Overview of Institut Curie 50
Mayo Clinic 51
Clinical Trial Overview of Mayo Clinic 51
Five Key Clinical Profiles 52


Appendix 167
Abbreviations 167
Definitions 167
Research Methodology 168
Secondary Research 168
About GlobalData 169
Contact Us 169
Disclaimer 169
Source 170


Hormone Sensitive Breast Cancer Therapeutics, Global, Clinical Trials by Region, 2014* 7
Hormone Sensitive Breast Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Hormone Sensitive Breast Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Hormone Sensitive Breast Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Hormone Sensitive Breast Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Hormone Sensitive Breast Cancer Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Hormone Sensitive Breast Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Hormone Sensitive Breast Cancer Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Hormone Sensitive Breast Cancer to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Hormone Sensitive Breast Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Hormone Sensitive Breast Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Hormone Sensitive Breast Cancer to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Hormone Sensitive Breast Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Hormone Sensitive Breast Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Hormone Sensitive Breast Cancer Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Hormone Sensitive Breast Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Hormone Sensitive Breast Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Hormone Sensitive Breast Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Hormone Sensitive Breast Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Hormone Sensitive Breast Cancer Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Hormone Sensitive Breast Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Hormone Sensitive Breast Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
Hormone Sensitive Breast Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Hormone Sensitive Breast Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Hormone Sensitive Breast Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
Hormone Sensitive Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 34
Hormone Sensitive Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 35
Hormone Sensitive Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 36
Hormone Sensitive Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 37
Hormone Sensitive Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 38
Hormone Sensitive Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Mylan Inc., 2014* 39
Hormone Sensitive Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Medivation, Inc., 2014* 40
Hormone Sensitive Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Cipla Ltd., 2014* 41
Hormone Sensitive Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bluefish Pharmaceuticals AB, 2014* 42
Hormone Sensitive Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt-Ingram Cancer Center, 2014* 43
Hormone Sensitive Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Japan Breast Cancer Research Group, 2014* 44
Hormone Sensitive Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2014* 45
Hormone Sensitive Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by British Columbia Cancer Agency, 2014* 46
Hormone Sensitive Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Saitama Medical University, 2014* 47
Hormone Sensitive Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut Claudius Regaud, 2014* 48
Hormone Sensitive Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut Bergonie, 2014* 49
Hormone Sensitive Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut Curie, 2014* 50
Hormone Sensitive Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2014* 51


Hormone Sensitive Breast Cancer Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Hormone Sensitive Breast Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Hormone Sensitive Breast Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Hormone Sensitive Breast Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Hormone Sensitive Breast Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Hormone Sensitive Breast Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Hormone Sensitive Breast Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Hormone Sensitive Breast Cancer Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Hormone Sensitive Breast Cancer to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Hormone Sensitive Breast Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Hormone Sensitive Breast Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Hormone Sensitive Breast Cancer to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Hormone Sensitive Breast Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Hormone Sensitive Breast Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Hormone Sensitive Breast Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Hormone Sensitive Breast Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Hormone Sensitive Breast Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Hormone Sensitive Breast Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Hormone Sensitive Breast Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
Hormone Sensitive Breast Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Hormone Sensitive Breast Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Hormone Sensitive Breast Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
GlobalData Methodology 168